Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NXL104/ceftazidime in complicated urinary tract infection
NCT00690378Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Countries
- 3
01
Overview
Phase 2, randomised, single-blind trial of avibactam in complicated urinary tract infection (cUTI) and acute pyelonephritis (2 arms), sponsored by Pfizer. Primary endpoint: Microbiological Outcome at Test of Cure. Started Nov 2008; status: completed.
02
Drugs
avibactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT00690378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690378.